The Trump administration’s 2025 drug policy agenda omits cannabis rescheduling, despite earlier signals of support, instead prioritizing fentanyl, border security, and addiction treatment. This omission, coupled with a...more
6/9/2025
/ Biden Administration ,
Cannabis Products ,
DEA ,
Department of Justice (DOJ) ,
Legislative Agendas ,
Marijuana ,
New Legislation ,
Opioid ,
Proposed Legislation ,
Regulatory Reform ,
Trump Administration
Movement on legalizing cannabis inches ahead on a federal level -
Cannabis rescheduling hearings began on January 21, 2025, to evaluate moving cannabis from Schedule I to Schedule III of the Controlled Substances Act as...more
3/28/2025
/ Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Congressional Investigations & Hearings ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Enforcement ,
Hemp ,
Licensing Rules ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
Regulatory Agenda ,
THC
Historic DEA marijuana rescheduling hearing opens, paused until mid-January -
Historic hearings to reconsider marijuana's federal status will start mid-January, as announced by U.S. DEA Judge John Mulrooney II. The focus...more
12/20/2024
/ Administrative Hearings ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
DEA ,
Food and Drug Administration (FDA) ,
Hemp ,
Marijuana ,
Marijuana Related Businesses ,
NIST ,
Proposed Legislation ,
Regulatory Agenda
The moment we have all been waiting for has finally happened. Today, the AP reported that the Drug Enforcement Administration (DEA) has accepted the recommendation of the U.S. Department of Health and Human Services (HHS) to...more
In a historic move by the federal government, the U.S. Department of Health and Human Services (HHS) on August 30 recommended that cannabis be moved from Schedule I to Schedule III of the Controlled Substances Act....more
There Has Been Little Movement in Federal Legalization. This has led to cannabis investors and companies to downgrade expectations for federal legalization and focus their strategies on state reform.
Federal lawmakers...more
7/27/2023
/ Banking Sector ,
Banks ,
Biden Administration ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Cannabis-Related Businesses (CRBs) ,
Cole Memorandum ,
Congressional Investigations & Hearings ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Hemp ,
Hemp Related Businesses ,
Information Reports ,
Interstate Commerce ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Medical Marijuana ,
Proposed Legislation ,
Regulatory Agenda ,
State and Local Government ,
Tax Revenues ,
THC